Mereo BioPharma Group Plc (MREO)
2.18
+0.05
(+2.35%)
USD |
NASDAQ |
Dec 09, 16:00
2.19
+0.01
(+0.46%)
After-Hours: 20:00
Mereo BioPharma Group Total Liabilities (Quarterly): 7.004M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics Plc | 201.59M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 8.601M |
| Autolus Therapeutics Plc | 396.50M |
| Bicycle Therapeutics Plc | 145.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.60M |
| Shareholders Equity (Quarterly) | 46.60M |
| Debt to Equity Ratio | 0.0085 |
| Current Ratio | 8.711 |
| Net Debt Paydown Yield | 0.35% |